河化股份(000953.SZ):股票繼續停牌,預計停牌時間不超過3個交易日
格隆匯8月1日丨河化股份(000953.SZ)公佈,2025年8月1日,公司收到銀億控股通知,相關各方正在積極推進本次交易的各項工作,交易對方系屬化工材料行業,但交易各方尚未簽署正式協議,整體交易方案仍在積極協商中,公司預計無法在2025年8月4日(星期一)上午開市起復牌。根據《深圳證券交易所股票上市規則》《深圳證券交易所上市公司自律監管指引第6號——停復牌》等相關規定,經向深圳證券交易所申請,公司股票自2025年8月4日(星期一)開市起繼續停牌,預計停牌時間不超過3個交易日。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.